Dudediligence.

Lantern Pharma Inc

LTRNNASDAQ · Pharmaceutical Preparations
Write an idea

Fundamentals

Oldest to newest
Net income, by quarter
−$4.5MSep ’24−$5.9MDec ’24−$4.5MMar ’25−$4.3MJun ’25−$4.2MSep ’25−$4.1MDec ’25−$3.3MMar ’26−$7.1MJun ’26
Fiscal years, by the month each ended
LineDec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Operating income−$12.6M−$14.4M−$17.9M−$22.2M−$18.0M
Net income−$12.4M−$14.3M−$16.0M−$20.8M−$17.1M
Operating cash flow−$10.6M−$12.8M−$14.3M−$17.8M−$15.7M
Free cash flow−$10.6M−$12.8M−$14.4M−$17.8M−$15.7M
Cash$51.5M$37.2M$21.9M$7.5M$4.4M
Shares outstanding11.1M10.9M10.7M10.8M11.3M